MYC gene rearrangements are found in approximately 5% to 15% of DLBCL cases, while BCL2 rearrangements are more common, occurring in about one-third of cases, mainly within the GCB subtype (27). The gene discussed is BCL2; the disease is diffuse large B-cell lymphoma.